Titan Pharmaceuticals Inc (TTNP) — Cash Flow Reinvestment Rate

Latest as of June 2016: 0.00x

Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2016, reinvesting $9.00K (capex $9.00K ) from operating cash flow of $13.51 Million. Explore how much does Titan Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$9.00K
Capex + Investments

Operating Cash Flow

$13.51 Million
USD

Capital Expenditures

$9.00K
USD

Titan Pharmaceuticals Inc Cash Flow Reinvestment Rate (1997–2016)

Historical reinvestment intensity for Titan Pharmaceuticals Inc across 3 annual periods. Also explore TTNP total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Titan Pharmaceuticals Inc (1997–2016)

Year-by-year capital reinvestment analysis for Titan Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Titan Pharmaceuticals Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 0.05x $342.00K $6.29 Million $171.00K ▼ -91.4%
2012 0.63x $1.15 Million $1.83 Million $1.15 Million ▲ +4377.3%
1997 0.01x $100.00K $7.10 Million $100.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow